Condition: Lymphedema · Edema · Sponsor: Fibralign Corporation
To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
This description comes directly from the study's public registry record.
Scully Hsu · 773-834-8038 · shsu@bsd.uchicago.edu
Always discuss trial participation with your own doctor first.
| The University of Chicago Biological Sciences Division/University of Chicago Medical Center | Chicago, Illinois, United States | Recruiting |
| MD Anderson | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04606030